Korean Zoetis Launches All-in-One Dog Dewormer 'Simparica Trio'

Animal health company Korean Zoetis has introduced "Simparica Trio," an all-in-one oral dewormer for dogs, to the South Korean market. The company has also appointed television personality Shin Dong-yup as its first advertising model, with commercials now airing on TV and social media channels.

Simparica Trio offers comprehensive parasite control, managing heartworm, ticks, fleas, and intestinal parasites like roundworms and hookworms with a single chewable tablet administered monthly. This convenient approach simplifies parasite prevention for dog owners.

“

As pet owners move beyond basic prevention to broadly consider the scope of prevention, ingredients, and ease of administration, we are introducing Simparica Trio.

The product is based on the isoxazoline class and was first approved by the U.S. Food and Drug Administration (FDA) in February 2020. It is formulated as a pork-flavored chewable tablet, designed to be easily consumed by dogs, similar to a treat. Korean Zoetis stated that the product caters to pet owners who increasingly consider the scope of prevention, ingredients, and ease of administration, aiming to set a new standard in the domestic market with its convenience and globally verified efficacy and safety.

While Simparica Trio is an FDA-certified veterinary medicine, it is available only by prescription from a veterinarian. This is a measure implemented by the FDA to manage potential rare side effects, ensuring responsible use.

“

With the convenience of managing multiple parasites with a single pill and efficacy/safety verified in the global market, we will present a new standard to domestic owners.